Immunic

IMUXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$100.969 M

$7.40 -6.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Immunic (IMUX) has a market capitalization of $101.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$97.2M

Loss-making

Shares outstanding

13,644,467

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#290OnKure TherapeuticsOKUR$102.3M
#291CellectisCLLS$101.5M
#292ImmunicIMUX$101.0M
#293NRX PharmaceuticalsNRXP$98.2M
#294PMV PharmaceuticalsPMVP$96.7M

What if Immunic were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,069,474

Per share 279,659× higher

Bitcoin $1.53T

$111,975.65

Per share 15,132× higher

Apple $5.02T

$367,605.61

Per share 49,676× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Immunic are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.